Surgical Robotics Technology

DePuy Synthes Acquires OrthoSpin


The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes**, acting through its affiliate, Synthes GmbH, has acquired the Israeli company, OrthoSpin, Ltd. OrthoSpin developed and manufactures a first-of-its kind technology – an automated strut system – which is used in conjunction with DePuy Synthes MAXFRAME™ Multi-Axial Correction System, an external ring fixation system. This acquisition is a clear example of Johnson & Johnson’s continued commitment to advancing innovation in the medtech space.

Ring fixation systems are a common treatment for correcting complex bone deformities, bone lengthening, setting complex fractures, and addressing issues such as nonunion. Currently, treatment necessitates manual strut adjustments by patients and caregivers daily. With this cutting-edge technology, strut adjustments are automated and may enhance the patient experience, potentially reducing the risk of negative clinical outcomes caused by unintended strut adjustment errors.

Deformity correction with ring fixation plays an important role in orthopaedics. DePuy Synthes has been committed to this area with the introduction of the MAXFRAME™ System in 2017, and most recently with the launch of new frame innovations and planned next generation software.  With the addition of the OrthoSpin technology, DePuy Synthes is better positioned to serve healthcare professionals and patients who benefit from these critical advancements during the complex post-surgery recovery period. 

“DePuy Synthes is deeply committed to patients who are in need of deformity correction surgery,” said Oray Boston***, Worldwide President, DePuy Synthes Trauma, Extremities, Craniomaxillofacial and Animal Health. “The acquisition of OrthoSpin clearly demonstrates our strong desire to help these patients navigate their recovery with more confidence and less uncertainty with their strut adjustments. It also demonstrates our commitment to bringing transformative Medtech advancements to the industry through the application of automated technology that addresses a wide range of orthopaedic challenges.”

Johnson & Johnson Innovation – JJDC, Inc. led the Series A financing of OrthoSpin in July 2018 and also led the Series B financing in March 2020. Earlier this year, OrthoSpin received 510(k) clearance from the U.S. Food and Drug Administration for its second generation, automated, digitally enabled external fixation system for orthopaedic treatments, the OrthoSpin G2 System, which is also licensed as a medical device (AMAR) in Israel.

Since its initial release, the OrthoSpin system has been used in numerous surgical procedures with positive feedback from surgeons and patients. Now that the acquisition is complete, DePuy Synthes will integrate the company and develop a robust supply chain before making the product widely available in the near future.

Source: DePuy Synthes.

*Comprising the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment
**DePuy Synthes represents the products and services of DePuy Synthes Sales, Inc. and its affiliates.
***Oray Boston is an employee of Medical Device Business Services, Inc.

Surgical Robotics Technology

Join thousands of Surgical Robotics Experts and get the latest updates straight to your inbox!